Director, Global Bio-innovations for the Biosciences Division, Life Science Solutions Group
Mark Federici’s Post
More Relevant Posts
-
Director, Global Bio-innovations for the Biosciences Division, Life Science Solutions Group
GRO Biosciences Closes $60M Series B Financing Co-Led by Atlas Venture and Access Biotechnology
https://venturebeat.com
-
Director, Global Bio-innovations for the Biosciences Division, Life Science Solutions Group
Cardurion Raises $260M to Advance Cardiovascular Assets
biospace.com
-
Director, Global Bio-innovations for the Biosciences Division, Life Science Solutions Group
Waypoint Bio Raises $14.5M in Seed Funding
https://www.finsmes.com
-
Director, Global Bio-innovations for the Biosciences Division, Life Science Solutions Group
Alumis cuts IPO size, but nets $250M for immune drug work
biopharmadive.com
-
Director, Global Bio-innovations for the Biosciences Division, Life Science Solutions Group
Halia Therapeutics to Unveil New Clinical Program Targeting the LRRK2 Protein for Alzheimer's Disease at Discovery Europe 2024
hjnews.com
-
Director, Global Bio-innovations for the Biosciences Division, Life Science Solutions Group
Huge launch
Xaira Therapeutics Launches with $1 Billion in Funding and Stellar Team
https://thehealthcaretechnologyreport.com
-
Director, Global Bio-innovations for the Biosciences Division, Life Science Solutions Group
Sands Capital raises $555M fund amid upturn in biotech ‘crossover’ investing
biopharmadive.com
-
Director, Global Bio-innovations for the Biosciences Division, Life Science Solutions Group
Ajax, aiming for a better JAK drug, raises $95M to begin first tests
biopharmadive.com
-
Director, Global Bio-innovations for the Biosciences Division, Life Science Solutions Group
Outstanding success and another step forward for gene therapy medicine
Regeneron gene therapy improves hearing in two children
biopharmadive.com
